Amryt Pharma PLC Sponsored ADR came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 66.67%. A quarter ago, it was expected that this company would post a loss of $0.09 per share when it actually produced a loss of $0.04, delivering a surprise of 55.56%.